Delayed solid phase immunologic assay
Abstract
A method for the determination of a substance present in a sample, which comprises: (a) contacting a sample containing a substance with: (i) a first immunological binding partner to the substance, wherein the first immunological binding partner is bound to biotin or a biotin-binding protein,(ii) a second immunological binding partner to the substance, wherein the second immunological binding partner is detectably labeled, and(iii) a biotin binding protein or biotin bound to a carrier;(b) incubating the components of step (a) for a period of time and under conditions sufficient to form an immune complex between the substance, the first immunological binding partner, the second immunological binding partner, and the carrier;(c) separating the carrier from the sample; and(d) determining the detectably labeled second immunological binding partner in either the sample or the carrier; wherein the reaction between the first immunological binding partner and the carrier occurs after, or substantially contemporaneously with, formation of an immune complex between the first immunological binding partner and the substance.
Term
Term ended
Projected expiry passed 6 May 2006, 20.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
Every citation, both waysCites: the store holds 8 of 9
| Document | Relation | Office | Category | Cited during |
|---|---|---|---|---|
| EP0160900A2 | Cites | European Patent Office (EPO) | YP | Search report |
| GB2074727A | Cites | United Kingdom | AD | Search report |
| DE2951678A1 | Cites | Germany | Y | Search report |
| US4228237A | Cites | United States of America | Y | Search report |
| US4253995A | Cites | United States of America | Y | Search report |
| US4343896A | Cites | United States of America | YD | Search report |
| WO8404171A1 | Cites | World Intellectual Property Organization (WIPO) | X | Search report |
| WO8500663A1 | Cites | World Intellectual Property Organization (WIPO) | X | Search report |
| The Journal of Histochemistry and Cytochemistry, Vol. 27, No. 8, August 1979, pages 1131-1139; The Histochem. Soc. Inc., US, J.L. GUESDON et al.: "The use of avidin-biotin interaction in immunoenzymatic techniques". | Non-patent | – | – | Search report |
21 members in 11 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 731470 | United States of America | – | |
| 73147085 | United States of America | A | |
| 73147085 | United States of America | A | |
| 731470 | – | – | – |
| US19850731470 | – | – | – |
Members21
| Document | Office | Kind | |
|---|---|---|---|
| DK212986D0 | Denmark | D0 | |
| PT82517A | Portugal | A | |
| GR861176B | Greece | B | |
| DK212986A | Denmark | A | |
| EP0201079A2 | European Patent Office (EPO) | A2 | |
| AU5704686A | Australia | A | |
| JPS6230963A | Japan | A | |
| ES554741A0 | Spain | A0 | |
| ES8801865A1 | Spain | A1 | |
| PT82517B | Portugal | B | |
| ES557705A0 | Spain | A0 | |
| ES8802346A1 | Spain | A1 | |
| EP0201079A3This record | European Patent Office (EPO) | A3 | |
| AU591667B2 | Australia | B2 | |
| US4935339A | United States of America | A | |
| CA1286605C | Canada | C | |
| EP0201079B1 | European Patent Office (EPO) | B1 | |
| AT137022T | Austria | T | |
| ATE137022T1 | Austria | T1 | |
| DE3650513D1 | Germany | D1 | |
| DE3650513T2 | Germany | T2 |
37 legal events, as 4 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Party data changed (patent owner data changed or rights of a patent transferred)RAP2 | RAP2 | EP | |
| Information on inventor provided after grant (corrected)ZAHRADNIK, RICHARDRIN2 | RIN2 | EP | |
| Transmission of propertyTP | TP | FR | |
| Patent ceasedCeasedPL | PL | CH | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)732E | 732E | GB | |
| Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents actLapsedNLV1 | NLV1 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fr: translation filedET | ET | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Corresponds to:REF | REF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Designated contracting statesAK | AK | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH | GRAH | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0201079
- Publication, DOCDB
- 0201079
- Publication, EPODOC
- EP0201079
- Application
- 86106173
- Application, DOCDB
- 86106173
- Application, EPODOC
- EP19860106173
Titles3
- German
- Verzögerter immunologischer Test in fester Phase
- English
- Delayed solid phase immunologic assay
- French
- Essai immunologique retardé en phase solide
Classification
- CPC, 7
- G01N33/538
- G01N33/54353
- Y10S435/81
- Y10S435/975
- Y10S436/824
- Y10S436/817
- Y10S530/862
- IPC, 11
- G01N33 53
- C07K14 00
- C07K14 575
- C07K14 585
- C07K14 61
- C07K16 00
- C07K19 00
- C12N15 02
- C12P21 08
- G01N33 538
- G01N33 543
Designated states1
- Contracting states, 1
- Sweden